{"id":2210,"date":"2021-11-26T18:55:00","date_gmt":"2021-11-26T18:55:00","guid":{"rendered":"https:\/\/digires.lt\/fact\/skleidzia-mela-apie-jav-registruota-patenta-ne-jis-nepriklauso-pfizer-ir-nera-susijes-su-vakcinomis\/"},"modified":"2023-01-13T15:02:21","modified_gmt":"2023-01-13T15:02:21","slug":"skleidzia-mela-apie-jav-registruota-patenta-ne-jis-nepriklauso-pfizer-ir-nera-susijes-su-vakcinomis","status":"publish","type":"fact","link":"https:\/\/digires.lt\/ru\/fact\/skleidzia-mela-apie-jav-registruota-patenta-ne-jis-nepriklauso-pfizer-ir-nera-susijes-su-vakcinomis\/","title":{"rendered":"Skleid\u017eia mel\u0105 apie JAV registruot\u0105 patent\u0105: ne, jis nepriklauso \u201ePfizer\u201c ir n\u0117ra susij\u0119s su vakcinomis"},"content":{"rendered":"\n<p>Socialini\u0173 tinkle vartotoj\u0173 d\u0117mes\u012f patrauk\u0117 vienas Jungtin\u0117se Amerikos Valstijose (JAV) registruotas patentas, suk\u0117l\u0119s gandus, es\u0105 tai \u2013 farmacijos kampanijos \u201ePfizer\u201c i\u0161radimas, kuriuo per nuotol\u012f bus sekami vis\u0173 pasiskiepijusi\u0173 nuo COVID-19 \u017emoni\u0173 kontaktai. \u0160i informacija \u2013 klaidinga.<\/p>\n\n\n<p><iframe loading=\"lazy\" src=\"https:\/\/g.delfi.lt\/projektai\/melo-detektorius\/i\/polygraph\/?type=1&amp;v1\" frameborder=\"0\" width=\"100%\" height=\"96px\"><\/iframe><\/p>\n<p>\u201eFacebook\u201c socialiniame tinkle pasidalinta JAV registruoto patento # US 11,107,588 B2 ekrano nuotrauka, \u0161alia jos paliktas komentaras, kuriame sakoma, es\u0105 min\u0117tas patentas priklauso pirm\u0105j\u0105 patvirtint\u0105 vakcin\u0105 nuo COVID-19 i\u0161radusiai kampanijai \u201ePfizer\u201c. Socialini\u0173 tinkl\u0173 vartotojai \u012ftik\u0117jo, kad patentas apra\u0161o technologij\u0105, skirt\u0105 vis\u0173 paskiepyt\u0173 nuo viruso \u017emoni\u0173 kontakt\u0173 atsekimui visame pasaulyje.<\/p>\n<p>I\u0161siai\u0161kinti, kad \u0161i informacija n\u0117ra teisinga \u2013 nesud\u0117tinga, pakanka atid\u017eiau panagrin\u0117ti, kas ra\u0161oma aptartame patente.<\/p>\n<p>Pirmiausia, \u0161is patentas nepriklauso ir n\u0117ra susij\u0119s su farmacijos gigante \u201ePfizer\u201c. Jis i\u0161duotas apra\u0161omos technologijos i\u0161rad\u0117j\u0173 i\u0161 Izraelio Gal Ehrlich ir Maier Fenster, patent\u0173 ir prek\u0117s \u017eenkl\u0173 teisinink\u0173 i\u0161 \u201eEhrlich &amp; Fenster\u201c, vardu.<\/p>\n<p><a href=\"https:\/\/www.reuters.com\/article\/factcheck-patent-contact-tracing-idUSL1N2RI25R\" target=\"_blank\" rel=\"noopener\">\u201eReuters\u201c \u017eurnalistams<\/a> vienas i\u0161 technologijos i\u0161rad\u0117j\u0173 G. Ehrlich patvirtino, kad patentas n\u0117ra susij\u0119s su vakcinomis.<\/p>\n<p>I\u0161 ties\u0173, \u0161iame patente apra\u0161oma technologija, kuri\u0105 b\u016bt\u0173 galima panaudoti sekant u\u017esikr\u0117tusi\u0173 virusu asmen\u0173 kontaktus ir vertinant rizikas u\u017esikr\u0117sti tuo pa\u010diu i\u0161laikant asmen\u0173 anonimi\u0161kum\u0105. Pana\u0161i\u0105 technologij\u0105, skirt\u0105 u\u017esikr\u0117tusi\u0173 SARS-Cov-2 virusu asmen\u0173 kontakt\u0173 sekimui, 2020 m. apra\u0161\u0117 portalas \u201eWired\u201c.<\/p>\n<p><a href=\"https:\/\/patentimages.storage.googleapis.com\/68\/80\/73\/6a17a66e9ec8c5\/US11107588.pdf\" target=\"_blank\" rel=\"noopener\">Patente apra\u0161omas<\/a> kontakt\u0173 atsekimo procesas, pasitelkiant elektroninius \u012frenginius. Tai, pavyzd\u017eiui, gal\u0117t\u0173 b\u016bti mobiliojo telefono program\u0117l\u0117. Prisijungus prie program\u0117l\u0117s vartotojui b\u016bt\u0173 sugeneruojamas identifikacinis numeris. Keletui toki\u0173 \u012frengini\u0173 atsid\u016brus netolimu atstumu \u012frenginiai gal\u0117t\u0173 dalytis ir keistis informacija, pagal kuri\u0105 b\u016bt\u0173 sugeneruojamas balas. Remiantis gauta informacija ir sugeneruotu balu, \u012frenginio tur\u0117tojas gal\u0117t\u0173 gauti jam pritaikyt\u0105 informacij\u0105 apie reikaling\u0105 gydym\u0105, be to, sugeneruotas balas pad\u0117t\u0173 daryti prognozes apie viruso plitim\u0105.<\/p>\n<p>Pana\u0161us b\u016bdas sekti COVID-19 plitimo eig\u0105 ir \u012fsp\u0117ti gyventojus apie tur\u0117t\u0105 kontakt\u0105 su u\u017esikr\u0117tusiais asmenimis apra\u0161ytas ir 2020 m. oficialioje Europos Parlamento svetain\u0117je patalpintame prane\u0161ime. \u010cia taip pat minima mobiliojo telefono program\u0117li\u0173 galima nauda, siekiant stabdyti viruso plitim\u0105 ir informuoti \u017emones sveikatos klausimais, ta\u010diau atkreiptas d\u0117mesys \u012f privatumo bei duomen\u0173 apsaugos u\u017etikrinim\u0105.<\/p>\n<p><strong>I\u0161vados<\/strong><\/p>\n<p>JAV registruotas patentas # US 11,107,588 B, skirtingai nei teigiama socialiniuose tinkluose, nepriklauso kampanijai \u201ePfizer\u201c. \u0160is patentas registruotas apra\u0161omos technologijos i\u0161rad\u0117j\u0173 i\u0161 Izraelio Gal Ehrlich ir Maier Fenster vardu. Patentuota technologija n\u0117ra tiesiogiai susijusi su vakcinomis nuo COVID-19, ji apra\u0161o b\u016bd\u0105 sekti u\u017esikr\u0117tusi\u0173j\u0173 virusu kontaktus i\u0161laikant asmen\u0173 privatum\u0105 ir tuo pa\u010diu teikiant jiems personalizuot\u0105 informacij\u0105 apie sveikat\u0105.<\/p>\n<ul>\n<li>\u0160altiniai<\/li>\n<li><a href=\"https:\/\/patentimages.storage.googleapis.com\/68\/80\/73\/6a17a66e9ec8c5\/US11107588.pdf\" target=\"_blank\" rel=\"noopener\">Patent No .: US 11,107,588 B2 METHODS AND SYSTEMS OF PRIORITIZING TREATMENTS , VACCINATION , TESTING AND \/ OR ACTIVITIES WHILE PROTECTING THE PRIVACY OF INDIVIDUALS<\/a><\/li>\n<li><a href=\"https:\/\/www.wired.com\/story\/covid-19-contact-tracing-apple-google\/\" target=\"_blank\" rel=\"noopener\">How Covid-19 Contact Tracing Works on Your Phone; wired.com<\/a><\/li>\n<li><a href=\"https:\/\/www.reuters.com\/article\/factcheck-patent-contact-tracing-idUSL1N2RI25R\" target=\"_blank\" rel=\"noopener\">Fact Check-Pictured patent is for contact tracing, not implantable 5G tracking; reuters.com<\/a><\/li>\n<li><a href=\"https:\/\/www.ipatent.co.il\/home\/\" target=\"_blank\" rel=\"noopener\">Ehrlich &amp; Fenster Patent and Trademark Attorneys; ipatent.co.il<\/a><\/li>\n<li><a href=\"https:\/\/www.europarl.europa.eu\/news\/lt\/headlines\/society\/20200429STO78174\/covid-19-sekimo-programeles-uztikrintas-privatumas-ir-duomenu-apsauga\" target=\"_blank\" rel=\"noopener\">COVID-19 sekimo program\u0117l\u0117s: u\u017etikrintas privatumas ir duomen\u0173 apsauga; europarl.europa.eu<\/a><\/li>\n<\/ul>","protected":false},"featured_media":0,"template":"","meta":{"inline_featured_image":false,"ub_ctt_via":""},"class_list":["post-2210","fact","type-fact","status-publish","hentry"],"acf":[],"_links":{"self":[{"href":"https:\/\/digires.lt\/ru\/wp-json\/wp\/v2\/fact\/2210","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/digires.lt\/ru\/wp-json\/wp\/v2\/fact"}],"about":[{"href":"https:\/\/digires.lt\/ru\/wp-json\/wp\/v2\/types\/fact"}],"wp:attachment":[{"href":"https:\/\/digires.lt\/ru\/wp-json\/wp\/v2\/media?parent=2210"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}